Application of recovered autologous blood transfusion in cesarean section for puerperas with high risk of hemorrhage

Objective To investigate the clinical application of recovered autologous blood transfusion in cesarean section for puerperas with high risk of hemorrhage.

Methods A total of 100 puerperas with cesarean section were selected, and they were preoperatively diagnosed with high-risk hemorrhage, including perilous placenta previa, placenta accreta, placental abruption, threatened uterine rupture, and scarred uterus. According to the different blood transfusion methods, 50 puerperas receiving autologous blood transfusion were assigned to observation group, and 50 puerperas receiving allogeneic blood transfusion were assigned to control group. Clinical indicators, blood routine tests, coagulation function, inflammatory factors, and postoperative adverse reactions were compared between the two groups.

Results The intraoperative blood loss, intraoperative blood transfusion volume, blood costs, total costs, operative duration, and hospitalization time in the observation group were significantly shorter or lower than those in the control group. Immediately after blood transfusion (T₁), there were no significant differences in blood routine indicators between the two groups (P>0.05). At the end of blood transfusion (T₂) and 24 hours after surgery (T₃), there was no significant difference in hematocrit (Hct) between the two groups (P>0.05), while the hemoglobin (Hb) and platelet (Plt) levels in the observation group were significantly higher than those in the control group (P < 0.05). At T₁, there were no significant differences in coagulation function indicators between the two groups (P>0.05). At T₂ and T₃, there were no significant differences in D-dimer (D-D) between the two groups (P>0.05), while the prothrombin time (PT), thrombin time (TT), and activated partial thromboplastin time (APTT) in the observation group were significantly shorter than those in the control group, and fibrinogen (Fib) was significantly higher in the observationgroup (P < 0.05).At 48 hours after blood transfusion, the serum procalcitonin (PCT) and interleukin-6 (IL-6) levels in the observation group were significantly lower than those in the control group (P < 0.05). The number of cases with allergic reactions, infections, and hypotension in the observation group was significantly lower than that in the control group, but there was no significant difference in the total incidence rate of adverse reactions between the two groups (P>0.05).

Conclusion Clinical application of recovered autologous blood transfusion in cesarean section for puerperas with high risk of hemorrhage shows remarkable effects.